A CLINICAL TRIAL TO DETERMINE THE EFFICACY OF A DIETARY FAT REDUCTION PROGRAM PROVIDED IN ADDITION TO SYSTEMIC ADJUVANT THERAPY IN THE MANAGEMENT OF PATIENTS WITH PRIMARY INVASIVE BREAST CANCER
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antineoplastics; Cyclophosphamide; Doxorubicin; Fluorouracil; Methotrexate; Paclitaxel; Tamoxifen
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms WINS
- 17 Sep 2013 Biomarkers information updated
- 27 Nov 2005 New trial record.